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Abstract
Background/aims To report alterations in visual acuity
and visual pathway structure over an interval of 1–3 years
in a cohort of children, adolescents and young adults who
have Wolfram syndrome (WFS) and to describe the range
of disease severity evident in patients with WFS whose
ages differed by as much as 20 years at first examination.
Methods Annual, prospective ophthalmological
examinations were performed in conjunction with retinal
nerve fibre layer (RNFL) analysis. Diffusion tensor MRIderived fractional anisotropy was used to assess the
microstructural integrity of the optic radiations (OR FA).
Results Mean age of the 23 patients with WFS in
the study was 13.8 years (range 5–25 years). Mean
log minimum angle resolution visual acuity was 0.66
(20/91). RNFL thickness was subnormal in even the
youngest patients with WFS. Average RNFL thickness in
patients with WFS was 57±8 µ or ~40% thinner than that
measured in normal (94±10 µ) children and adolescents
(P<0.01). Lower OR FA correlated with worse visual acuity
(P=0.006). Subsequent examinations showed declines
(P<0.05) in visual acuity, RNFL thickness and OR FA at
follow-up intervals of 12–36 months. However, a wide
range of disease severity was evident across ages: some
of the youngest patients at their first examination had
deficits more severe than the oldest patients.

Conclusion The genetic mutation of WFS causes
damage to both pregeniculate and postgeniculate regions
of the visual pathway. The damage is progressive. The
decline in visual pathway structure is accompanied by
declines of visual function. Disease severity differs widely
in individual patients and cannot be predicted from their
age.
Introduction
Wolfram syndrome (WFS), also known as
DIDMOAD, was first described in 1938 by
Wolfram and Wagener.1 It is a rare, autosomal recessive syndrome characterised by
a cluster of symptoms including diabetes
insipidus (DI), diabetes mellitus (DM),
optic nerve atrophy (OA) and sensorineural
deafness (D). WFS can result in a shortened
lifespan.2 3 WFS is caused by mutations in the
WFS1 or WFS2 genes (OMIM 222300). WFS1
encodes a transmembrane protein localised
to the endoplasmic reticulum (ER) named

Key messages
What is known?
The hallmarks of Wolfram syndrome are bilateral optic
atrophy, diabetes mellitus and deafness.

What are the new findings?
►► First report of follow-up of a large cohort of patients

with Wolfram syndrome documenting longitudinal
decline in visual acuity and retinal nerve fibre layer.
►► First report showing a correlation of subnormal
visual acuity in Wolfram syndrome with structural
abnormalities of the optic radiations.

How might these results change the focus of
clinical practice?
Better appreciation of postgeniculate and pregeniculate
visual neuropathy of Wolfram syndrome to use as
markers in recently initiated pharmacological therapy
trials.

wolframin, which plays a crucial role in maintaining ER homeostasis, including calcium
regulation, redox regulation, ER stress signalling and cell death.4–8 WFS2 (also known as
CISD2) encodes ER intermembrane small
protein, which plays a role in ER calcium
homeostasis.9 10 WFS is associated with lower
volume of the brainstem as well as cerebellum
and reduced myelination throughout the
brain (Lugar et al; Hershey et al). WFS also
damages afferent visual pathway neurons.11–14
The reason for the selective neuronal damage
remains unclear.
The
Washington
University
WFS
Research Study has examined a cohort of
children, adolescents and young adults
longitudinally.14–18 Cognitive, neurological,
audiological and ophthalmological measures
are performed annually using standardised
protocols, supplemented by magnetic resonance brain imaging (MRI). The current
report describes how visual acuity, retinal
nerve fibre layer (RNFL) thickness and the
optic radiations of the geniculostriate cerebral
visual pathways are affected at a cross-section
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Table 1 Prevalence of ophthalmic findings in the 23
patients with Wolfram syndrome
Study parameter

Percentage
patients affected

Visual acuity <0.3 logMAR
RNFL thinning ≤80 μ

96 (22/23)
100 (23/23)

Visual field reduced sensitivity and/or
scotoma

100 (23/23)

Dyschromatopsia

96 (22/23)

Optic nerve pallor

96 (22/23)

Optic nerve cup:disc ratio ≥0.4

39 (9/23)

Afferent pupillary defect

65 (15/23)

Nystagmus

43 (10/23)

Strabismus
Cataract

43 (10/23)
22 (5/23)

logMAR, log minimum angle resolution; RNFL, retinal nerve fibre
layer.

of ages and longitudinally. A secondary goal was to show
the wide range of disease severity evident in patients with
WFS.
Subjects and methods
The 23 participants were recruited through the Washington University Wolfram Syndrome Registry website
to participate in standardised evaluations across
domains known to be associated with WFS at an annual
Washington University WFS Research Clinic. Minimal
diagnostic criteria to enrol in the registry are: (A) the
diagnosis of insulin-dependent DM and optic atrophy by
a physician before 18 years of age or (B) genetic confirmation of a WFS1 mutation. Informed consent from
parents for minor participants or from adult participants
was obtained prior to study enrolment.
Ophthalmic measures
A comprehensive quantitative ophthalmic examination
was performed by one of the authors (JH or LT), including
documentation of strabismus, nystagmus, binocular
perception, pupillary function, slit lamp biomicroscopy
and fundoscopic examination. These clinical measures
were supplemented by laboratory testing of RNFL thickness, Humphrey Visual Field Analysis, colour vision and
fundus photography as described in detail in a previous
report.18 Here we confine the description to testing of
visual acuity and RNFL thickness as measures of disease
progression. Best-corrected distance logMAR visual
acuity (CDVA) was recorded for each subject using Early
Treatment Diabetic Retinopathy Study optotypes.19 RNFL
thickness was measured by Optical Coherence Tomography (OCT, Zeiss CirrusHD-OCT, 4000–5444 version
4.5.1.11; Carl ZeissMeditec, Dublin, California, USA).
Normative values for RNFL thickness were obtained from
age-matched controls tested in our laboratory who had
normal visual acuity and no neuroretinal abnormalities.
2

Diffusion tensor MRI (DT-MRI)
Scans were acquired in awake, unsedated patients on a
Siemens 3T Tim Trio MRI scanner at Washington University. The DT-MRI echo planar sequence consisted of 27
directions with the b-values ranging from 0 s/mm2 to
1400 s/mm2. Transverse acquisition, TR=12 300, TE=108,
voxel resolution=1.98×1.98 × 2 mm, time=5:44 min.
DT-MRI optic radiation images were atlas transformed,
and measures of white matter microstructural integrity
(fractional anisotropy (FA)) were computed.20 21 Probabilistic tractography was performed using FMRIB’s
Diffusion Toolbox. Masks for tractography were created
using FSLView. To track the optic radiations, masks were
placed bilaterally on the lateral geniculate nucleus and
the striate cortex (area V1) calcarine sulcus, and probability distributions were generated between them. The
resulting distributions were then thresholded at 1% to
remove extraneous pathways and converted into binary
masks for the purpose of extracting mean FA.
Statistical analysis
Variables were tested for normality using the Kolmogorov-Smirnov test. Measures were obtained for each eye.
Visual deficits in WFS are generally symmetrical17 18; in
the cohort reported here there were no significant differences between right and left eyes for CDVA (P=0.37) or
RNFL thickness (P=0.46). To minimise comparisons and
improve clarity in the results, we averaged by combining
left and right values. Relationships between age, CDVA
and RNFL measures were assessed using Pearson’s r.
Ophthalmological and DT-MRI measures were compared
using the related samples Wilcoxon signed rank test for
small sample sizes. All analyses were performed employing
Statistical Package for the Social Sciences software (SPSS
V.22). A P value of <0.05 was considered significant.
Results
For the 23 patients included in this analysis, mean age
was 13.8 years (range, 5–25 years); median 11.3 years,
that is, half of the patients were <12 years of age. Sixty-five
per cent (15) were female and 35% (8) were male. Seventy
per cent (16) were Caucasian, 13% (3) were Hispanic and
17% (4) were mixed race. Average age at detection of
visual impairment by an outside examiner before enrolment in the study was 9.1±4.2 years (range 3–17 years).
The average time between vision impairment detection
and enrolment in the study was 4.8±3.7 years. Impaired
vision and optic disc pallor (96% of patients) were diagnosed when children were examined by an eye care
provider after experiencing difficulty with visual tasks in
elementary school. The prevalence of ophthalmic findings are listed in table 1. These rates are similar to those
reported previously in a subset of this cohort.18
At entrance into the study, all 23 patients (100%) were
able to cooperate for measurement of CDVA; RNFL
measurement was achieved in 20 patients (87%), and
DT-MRI scans of the optic radiations were obtained in
19 patients (83%). The combination of low-vision-related
Hoekel J, et al. BMJ Open Ophth 2016;0:e000081. doi:10.1136/bmjophth-2017-000081
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Table 2 Number of patients tested at entrance
examination into the study and retested at annual follow-up
intervals after entrance

Visual acuity
Retinal nerve
fibre layer
DT-MRI optic
radiation FA

Entrance

1-year
follow-up

2-year
follow-up

3-year
follow-up

23
20

18
14

14
11

11
10

19

13

9

6

DT-MRI, diffusion tensor MRI; FA, fractional anisotropy.

unsteady visual fixation, neurodevelopmental disability
and/or immaturity prevented testing of the RNFL
in three patients and contraindications for MRI (eg,
cochlear implants and braces) precluded scanning in
four patients. Table 2 shows the number of patients who
have been enrolled for 1–3 years and thus the number
retested at those intervals. About half of patients (11/23)
have 3 years of CDVA test data available for longitudinal
analysis (table 2).
Age-related trends for visual acuity, RNFL and optic radiation
FA
Visual acuity (CDVA) as a function of WFS patient age
is shown in figure 1. The CDVA at entrance examination is plotted for each of the 23 patients. Lines joining

Figure 2 Retinal nerve fibre layer (RNFL) thickness versus
age in patients with WFS (white dots) and in age-matched
normal subjects (black dots). Lines join sequential annual
measures of the same patient with WFS. WFS, Wolfram
syndrome.

Figure 1 Visual acuity (logMAR units) versus patient age.
Lines join sequential annual measures of individual patients
with WFS. logMAR, log minimum angle resolution; WFS,
Wolfram syndrome.
Hoekel J, et al. BMJ Open Ophth 2016;0:e000081. doi:10.1136/bmjophth-2017-000081

data points represent the CDVA obtained at annual
follow-up examinations for individual patients. CDVA was
a mean 20/91 (logMAR: 0.66), with a range of 20/25 to
20/40 000 (logMAR: 0.9–3.3). CDVA was 20/40 or worse
in 91% of patients (21/23).
RNFL thickness is a measure of the health of anterior
(pregeniculate) visual pathway axons; RNFL as a function
of patient age is shown in figure 2. The RNFL thickness at entrance examination is plotted for 20 patients
(20/23; three children could not perform the test reliably). Lines joining data points represent the CDVA
obtained at annual follow-up examinations for individual
patients. Seven of the 20 patients (35%) had one or
more follow-up RNFL values that exceeded the entrance
value (upward slope of the line joining values). It would
be difficult to explain these upward deflections as true
3
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Figure 4 Optic radiation fractional anisotropy versus
visual acuity (logMAR units) in patients with WFS. Measures
obtained at entrance examination. logMAR, log minimum
angle resolution; WFS, Wolfram syndrome.

Figure 3 Retinal nerve fibre layer mean thickness for
patients with WFS versus controls. WFS, Wolfram syndrome.

increases in RNFL thickness; they likely represent ‘noise’
inherent in measurement of RNFL in patients who have
subnormal vision and fixation instability. RNFL thickness
in patients with WFS (figure 3) averaged 57±8 µ, or 40%
thinner than that measured in normal (94±10 µ) children
and adolescents. The difference between mean RNFL
thickness in WFS patients versus controls was significant
(year 1, n=20, Z score=−4.30, P<0.01). RNFL thickness
was not correlated with CDVA (r=– 0.07, P=0.70).
Optic radiation FA measures the health of posterior
(postgeniculate) axons (figure 4). FA is a sensitive indicator of white matter injury22 and can detect damage
even when standard MR images appear normal.23–27 In
patients with WFS, lower optic radiation FA (figure 4)
correlated strongly with worse CDVA (year 1, n=19,
rs=−0.60, P=0.006).
A downward trend is evident in the regression line of
figure 1—worse CDVA at older age—and in the regression
line of figure 2—thinner RNFL at older age. However, the
data of both figures show a wide range of disease severity.
Some young patients with WFS had poor CDVA and thin
RNFL, whereas some older patients had comparatively
good CDVA and thicker RNFL. The range of severity
independent of age is evident in the fact that correlation
with age was non-significant for CDVA (P=0.44), RNFL
(P=0.11) and optic radiation FA (P=0.94).
In normal adults, thinner RNFL has been associated
with older age, longer axial length (AL) of the eye and
4

smaller optic disc area.28 AL was not measured in our
patients so we used spherical refractive error as a proxy;
hyperopic eyes tend to be shorter and myopic eyes tend
to be longer. Neither age, refractive error nor disc area
were correlated with thinner RNFL in our Wolfram
cohort (age, P=0.44; spherical refractive error, P=0.13;
optic disc area, P=0.39).
There were no significant differences between male
and female patients with regard to entrance CDVA
(P=0.71), RNFL thickness (P=0.36) or OR FA (P=0.65).
Comparison of entrance year measures to follow-up year
measures
To assess disease progression, measures obtained at
entrance were compared with measures obtained in
successive annual follow-up examinations. Because
patients in this longitudinal cohort study are enrolled as
they are referred to our centre, patients enrolled earlier
in the study have longer follow-up and those enrolled
recently have shorter follow-up. Table 1 shows the
number enrolled (23 patients) and the lower numbers
measured at each year of follow-up.
In the 11 patients measured annually for 3 years, CDVA
declined significantly from a mean logMAR 0.61±0.37 to
logMAR 0.80±0.42 (Wilcoxon signed rank test, P<0.05).
Over the same interval, RNFL thickness declined from
an average 59±6 µ to 55±4 µ (P<0.05). Did patients with
worse CDVA at the entrance examination and/or thinner
RNFL thickness at entrance examination have greater
rates of loss at follow-up examinations? To examine this
issue, the slope of the loss was calculated for each patient
and then correlated with the entrance values. The slopes
did not correlate with the entrance values, that is, the
most severely affected patients did not have steeper rates
of loss (CDVA mean=0.05 logMAR/year, P=0.35; RNFL
mean=−0.3 micron/year, P=0.54).
Hoekel J, et al. BMJ Open Ophth 2016;0:e000081. doi:10.1136/bmjophth-2017-000081
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For OR FA, the decline from entrance (mean
0.45±0.03) to 1 year follow-up (0.43±0.03; 13 patients)
was significant (P<0.05). Lower numbers of patients at
the 2-year and 3-year follow-up (nine patients and six
patients, respectively) likely account for non-significant
statistical declines at the longer OR FA retesting intervals.
Discussion
The goal of the current study was to answer three questions. First, how does visual function and structure
relate to patient age in WFS? Second, how widely does
visual disease severity range in a sizeable cohort of WFS
patients? Third, does visual function decline over time in
WFS patients, for both pregeniculate regions of the visual
pathway (RNFL) and postgeniculate regions (OR FA)?
Our results show that visual function and structure in
WFS are related to patient age. Considering the cohort
as a whole, younger patients tend to have better CDVA
(figure 1) and RNFL thickness (figure 2) than older
patients. All of the patients with WFS—from the youngest
at age 5 years to the oldest at age 25 years at entrance into
the study—had significantly thinner RNFL thickness
than any of the age-matched control subjects (figure 2).
However, the variation of disease severity within the WFS
cohort is wide. Many younger patients have worse CDVA
and a thinner RNFL than some older patients. In patients
followed for 3 years, CDVA and RNFL declined significantly. Zmysloska et al reported recently also decline
of RNFL in patients with WFS followed on average
22 months.29
OR FA in patients with WFS has been shown to be
reduced significantly compared with both age-matched
healthy and diabetic controls14 (diabetic controls are
necessary because DM is one of the diagnostic criteria
for WFS and DM can impair brain function and structure).27 30–33 OR FA is a sensitive indicator of postlateral
geniculate nucleus visual axon health and myelination.22 26
FA measures the movement of water within and parallel
to neuronal axonal fibres. In normal children and adolescents, FA increases with age.34 When axons or myelin
are damaged, FA can decrease.23 Previous analyses have
found that OR FA is lower in patients with WFS than in
controls.35 We found a significant correlation between
optic radiation FA and CDVA in our WFS patients
(figure 4). Lower OR FA was associated with lower CDVA.
Taken together, these results indicate damage to pregeniculate (RNFL) and postgeniculate visual axons (OR
FA) in WFS. The results allow better appreciation of the
postgeniculate and pregeniculate visual neuropathy of
WFS. These functional and structural tests may be helpful
as outcome measures in future therapeutic trials.
In previous reports of entrance examination findings
in a portion of this WFS cohort, the phenotypic characteristics were catalogued.17 18 The visual characteristics
included subnormal CDVA, impaired colour vision, visual
field deficits, vision loss-related nystagmus, strabismus,
afferent pupillary defects and optic nerve head pallor. A
previous report of neuroimaging compared a portion of
Hoekel J, et al. BMJ Open Ophth 2016;0:e000081. doi:10.1136/bmjophth-2017-000081

this WFS cohort to age-matched controls.14 That report
documented that WFS patients have reduced brainstem
(midbrain; pons) and cerebellar volumes at early ages.
The reduction of RNFL thickness, OR FA, brainstem and
cerebellar volumes at even the earliest ages imply that
the brain abnormalities of WFS are both neurodevelopmental and neurodegenerative. The WFS1 mutations
may cause hypoplasia of neurons and their axonal projections, as well as gradual atrophy of neurons. The current
study documents that the neuronal damage—while variable across patients with WFS—encompasses the anterior
as well as the posterior visual pathway and worsens with
age.
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